Overview

Evaluation of ZK 6032924 in Probable Alzheimer's Disease Patients Versus Healthy Volunteers and the Radiation Dosimetry of ZK 6032924 in Healthy Volunteers

Status:
Completed

Trial end date:
2010-01-01

Target enrollment:

Participant gender:

Summary

PET (positron emission tomography) imaging with BAY85-8101 (ZK 6032924) in patients with Alzheimer's Disease compared to healthy volunteers.

Phase:

Phase 1

Details

Lead Sponsor:

Bayer